S H Kennedy

Summary

Country: Canada

Publications

  1. ncbi Sexual dysfunction before antidepressant therapy in major depression
    S H Kennedy
    Department of Psychiatry, University of Toronto, Ontario, Canada
    J Affect Disord 56:201-8. 1999
  2. ncbi Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis
    R M Bagby
    Clarke Institute of Psychiatry, Toronto, Ontario, Canada
    J Affect Disord 45:161-6. 1997
  3. ncbi Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study
    J H Meyer
    Clarke Institute of Psychiatry, Department of Psychiatry, University of Toronto, Ont, Canada
    Am J Psychiatry 156:1029-34. 1999
  4. ncbi Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine
    S H Kennedy
    Department of Psychiatry, University of Toronto, Centre for Addiction and Mental Health, Ontario, Canada
    J Clin Psychiatry 61:276-81. 2000
  5. ncbi Rumination and distraction in major depression: assessing response to pharmacological treatment
    R M Bagby
    Department of Psychiatry, University of Toronto, Canada
    J Affect Disord 55:225-9. 1999
  6. ncbi Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity
    R M Bagby
    Department of Psychiatry, University of Toronto and McMaster University Medical School, Ontario, Canada
    Psychiatry Res 86:211-6. 1999
  7. ncbi Comparisons of men with full or partial eating disorders, men without eating disorders, and women with eating disorders in the community
    D B Woodside
    Department of Psychiatry, The Toronto Hospital, 200 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4
    Am J Psychiatry 158:570-4. 2001
  8. ncbi Increased left posterior parietal-temporal cortex activation after D-fenfluramine in women with panic disorder
    J H Meyer
    The Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Clarke Division, 250 College Street, M5T 1R8, Toronto, Ontario, Canada
    Psychiatry Res 98:133-43. 2000
  9. doi The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder
    C Y Yim
    Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada
    Eur Psychiatry 27:223-8. 2012
  10. ncbi Clinical guidelines for the treatment of depressive disorders. V. Combining psychotherapy and pharmacotherapy
    Z V Segal
    Department of Psychiatry and Psychology, University of Toronto, Toronto, Ontario
    Can J Psychiatry 46:59S-62S. 2001

Detail Information

Publications20

  1. ncbi Sexual dysfunction before antidepressant therapy in major depression
    S H Kennedy
    Department of Psychiatry, University of Toronto, Ontario, Canada
    J Affect Disord 56:201-8. 1999
    ..The purpose of this report is to define the frequency of sexual dysfunction (SD) in 134 patients with MD and examine the relationship between SD and demographic, clinical and personality variables...
  2. ncbi Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis
    R M Bagby
    Clarke Institute of Psychiatry, Toronto, Ontario, Canada
    J Affect Disord 45:161-6. 1997
    ..A 2 (high angry hostile/low angry hostile) x 3 (medication type) analysis of variance (ANOVA) was non-significant, indicating no differential treatment effects...
  3. ncbi Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study
    J H Meyer
    Clarke Institute of Psychiatry, Department of Psychiatry, University of Toronto, Ont, Canada
    Am J Psychiatry 156:1029-34. 1999
    ..The objective of this study was to evaluate 5-HT2 receptors in depressed patients who were medication-free and who had not made recent suicide attempts...
  4. ncbi Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine
    S H Kennedy
    Department of Psychiatry, University of Toronto, Centre for Addiction and Mental Health, Ontario, Canada
    J Clin Psychiatry 61:276-81. 2000
    ....
  5. ncbi Rumination and distraction in major depression: assessing response to pharmacological treatment
    R M Bagby
    Department of Psychiatry, University of Toronto, Canada
    J Affect Disord 55:225-9. 1999
    ..RST has been shown to predict prolonged depression in samples of non-clinical, untreated individuals with mild to moderate depression but has not been tested in samples of depressed patients undergoing treatment...
  6. ncbi Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity
    R M Bagby
    Department of Psychiatry, University of Toronto and McMaster University Medical School, Ontario, Canada
    Psychiatry Res 86:211-6. 1999
    ....
  7. ncbi Comparisons of men with full or partial eating disorders, men without eating disorders, and women with eating disorders in the community
    D B Woodside
    Department of Psychiatry, The Toronto Hospital, 200 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4
    Am J Psychiatry 158:570-4. 2001
    ..The authors compared 62 men who met all or most of the DSM-III-R criteria for eating disorders with 212 women who had similar eating disorders and 3,769 men who had no eating disorders on a wide variety of clinical and historical variables...
  8. ncbi Increased left posterior parietal-temporal cortex activation after D-fenfluramine in women with panic disorder
    J H Meyer
    The Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Clarke Division, 250 College Street, M5T 1R8, Toronto, Ontario, Canada
    Psychiatry Res 98:133-43. 2000
    ..Functional pathology in the left parietal-superior temporal cortex in panic disorder may be related to abnormal modulation by serotonin...
  9. doi The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder
    C Y Yim
    Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada
    Eur Psychiatry 27:223-8. 2012
    ..This sub-group post-hoc analysis preliminarily explores and examines the association between overweight/obesity and cognitive function in euthymic individuals with bipolar disorder...
  10. ncbi Clinical guidelines for the treatment of depressive disorders. V. Combining psychotherapy and pharmacotherapy
    Z V Segal
    Department of Psychiatry and Psychology, University of Toronto, Toronto, Ontario
    Can J Psychiatry 46:59S-62S. 2001
    ..CONCLUSIONS: Combined treatment with psychotherapy and pharmacotherapy is widely used in clinical practice. The recommendations for use of combined treatment are, however, based on only a limited evidence base...
  11. doi Treating each and every depressed patient
    S H Kennedy
    University Health Network, University of Toronto, Toronto, Ontario, Canada
    J Psychopharmacol 22:19-23. 2008
    ....
  12. pmc Quality of life: an important dimension in assessing the treatment of depression?
    S H Kennedy
    Mood and Anxiety Disorders Program, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Ont
    J Psychiatry Neurosci 26:S23-8. 2001
    ..Despite the limitations of these questionnaires, they provide an important additional dimension to the evaluation of treatment with antidepressant medications...
  13. ncbi Personality and symptom profiles of the angry hostile depressed patient
    R M Bagby
    Clarke Institute of Psychiatry, Toronto, Ontario, Canada
    J Affect Disord 45:155-60. 1997
    ..The high angry hostile patients were rated as less interpersonally agreeable and less conscientious than low angry hostile patients. These results provide only partial support for the angry hostile subtype of depression...
  14. ncbi Investigating associations between cortisol and cognitive reactivity to sad mood provocation and the prediction of relapse in remitted major depression
    K K Chopra
    Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada Centre for Addiction and Mental Health, Toronto, Ontario, Canada Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
    Asian J Psychiatr 1:33-6. 2008
    ..The current analysis examined whether salivary cortisol levels could also predict relapse in these same individuals...
  15. ncbi The effect of bipolar I disorder and major depressive disorder on workforce function
    R S McIntyre
    Department of Psychiatry, University of Toronto, ON, Canada
    Chronic Dis Can 28:84-91. 2008
    ..5 to 0.9). The data herein underscore the pernicious effect of BD on workforce function, and suggest that opportunistic screening for BD in all individuals utilizing employment assistance programs for depression might be warranted...
  16. ncbi Measuring depressive symptoms in the naturalistic primary-care setting
    R S McIntyre
    Department of Psychiatry, University of Toronto, Toronto, ON, Canada
    Int J Clin Pract 61:1278-82. 2007
    ..A quantifiable critical objective in the management of depression is to achieve and sustain full symptomatic remission. The HAMD-7 is a depression metric validated in both tertiary and primary-care settings...
  17. ncbi Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments
    S H Kennedy
    Department of Psychiatry, University of Toronto, Toronto, Ontario
    Can J Psychiatry 46:38S-58S. 2001
    ..There is limited evidence for the use of specific medications to treat subtypes of MDD. There is emerging evidence to support augmentation and combination strategies for patients previously nonresponsive to medication...
  18. ncbi Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection
    C T Lai
    Department of Psychiatry, Mackenzie Health Sciences Centre, University of Alberta, Edmonton, Canada
    J Chromatogr B Biomed Sci Appl 749:275-9. 2000
    ..The calibration curves were linear, with typical r2 values >0.99. The assay was highly reproducible and gave peaks with excellent chromatographic properties...
  19. ncbi The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study
    J H Meyer
    Clarke Division, Centre for Addictions and Mental Health, Department ofPsychiatry, University of Toronto, Ontario, Canada
    Am J Psychiatry 158:78-85. 2001
    ..The objective of this study was to evaluate the effect of 6 weeks of paroxetine treatment on 5-HT(2A) receptors in depressed patients...
  20. ncbi A trial of isocarboxazid in the treatment of bulimia nervosa
    S H Kennedy
    Department of Psychiatry, University of Toronto, Ontario, Canada
    J Clin Psychopharmacol 8:391-6. 1988
    ..There were no serious adverse effects from this monoamine oxidase inhibitor therapy, although over 50% of patients elected to discontinue isocarboxazid 1 year after the study...